Regulation of hepatocyte fate by interferon-γ.

[1]  Jean S. Campbell,et al.  Liver regeneration. , 2012, Journal of hepatology.

[2]  E. Jaeckel,et al.  Mouse Models for Experimental Autoimmune Hepatitis: Limits and Chances , 2010, Digestive Diseases.

[3]  B. Saha,et al.  Gene modulation and immunoregulatory roles of interferon gamma. , 2010, Cytokine.

[4]  K. Wood,et al.  Role of T cells in graft rejection and transplantation tolerance , 2010, Expert review of clinical immunology.

[5]  G. Michalopoulos.  Liver regeneration after partial hepatectomy: critical analysis of mechanistic dilemmas. , 2010, The American journal of pathology.

[6]  A. Zhu,et al.  Systemic Treatment of Hepatocellular Carcinoma: Dawn of a New Era? , 2010, Annals of Surgical Oncology.

[7]  P. Malfertheiner,et al.  Hepatocellular Carcinoma – Epidemiological Trends and Risk Factors , 2009, Digestive Diseases.

[8]  A. Billiau,et al.  Interferon-gamma: a historical perspective. , 2009, Cytokine & growth factor reviews.

[9]  I. N. Crispe,et al.  The liver as a lymphoid organ. , 2009, Annual review of immunology.

[10]  K. Kanki,et al.  Control of ER stress by a chemical chaperone counteracts apoptotic signals in IFN-γ-treated murine hepatocytes , 2009, Apoptosis.

[11]  Fang Zhou,et al.  Molecular Mechanisms of IFN-γ to Up-Regulate MHC Class I Antigen Processing and Presentation , 2009, International reviews of immunology.

[12]  King-Jen Chang,et al.  Variations in Interferon Gamma Receptor Gene Expression during Liver Regeneration after Partial Hepatectomy in Rats , 2009, The American surgeon.

[13]  Sung‐Gyu Lee,et al.  Review : Liver Transplantation , 2009 .

[14]  David E Levy,et al.  IFNgamma signaling-does it mean JAK-STAT? , 2008, Cytokine & growth factor reviews.

[15]  Shusen Zheng,et al.  Activation of innate immunity (NK/IFN-gamma) in rat allogeneic liver transplantation: contribution to liver injury and suppression of hepatocyte proliferation. , 2008, American journal of physiology. Gastrointestinal and liver physiology.

[16]  T. Taniguchi,et al.  The IRF family transcription factors in immunity and oncogenesis. , 2008, Annual review of immunology.

[17]  W. Jeong,et al.  Abrogation of the antifibrotic effects of natural killer cells/interferon-gamma contributes to alcohol acceleration of liver fibrosis. , 2008, Gastroenterology.

[18]  G. van Loo,et al.  Hepatic tumor necrosis factor signaling and nuclear factor-kappaB: effects on liver homeostasis and beyond. , 2007, Endocrine reviews.

[19]  R. Sun,et al.  Impairment of liver regeneration correlates with activated hepatic NKT cells in HBV transgenic mice , 2007, Hepatology.

[20]  Guohua Yang,et al.  IFITM1 plays an essential role in the antiproliferative action of interferon-γ , 2007, Oncogene.

[21]  G. Tiegs.  Cellular and cytokine-mediated mechanisms of inflammation and its modulation in immune-mediated liver injury. , 2007, Zeitschrift fur Gastroenterologie.

[22]  G. Feldmann,et al.  Inducible Nitric Oxide Synthase (iNOS) Activity Could Be Responsible for Resistance or Sensitivity to IFN-γ-Induced Apoptosis in Several Human Hepatoma Cell Lines , 2006 .

[23]  W. Jeong,et al.  STAT1 inhibits liver fibrosis in mice by inhibiting stellate cell proliferation and stimulating NK cell cytotoxicity , 2006, Hepatology.

[24]  M. Zeniya,et al.  Interferon-gamma produced by interleukin-12-activated tumor infiltrating CD8+T cells directly induces apoptosis of mouse hepatocellular carcinoma. , 2006, Journal of hepatology.

[25]  W. Jeong,et al.  STAT1 contributes to dsRNA inhibition of liver regeneration after partial hepatectomy in mice , 2006, Hepatology.

[26]  D. Harrison,et al.  Growth factor attenuation of IFNγ‐mediated hepatocyte apoptosis requires p21waf−1 , 2006, International journal of experimental pathology.

[27]  M. Ziol,et al.  Interferon gamma‐secreting HCV‐specific CD8+ T cells in the liver of patients with chronic C hepatitis: relation to liver fibrosis – ANRS HC EP07 study * , 2006, Journal of viral hepatitis.

[28]  S. Friedman,et al.  Anti-fibrotic activity of NK cells in experimental liver injury through killing of activated HSC. , 2006, Journal of Hepatology.

[29]  D. Rockey,et al.  Interferon gamma‐1b for the treatment of fibrosis in chronic hepatitis C infection , 2006, Journal of viral hepatitis.

[30]  W. Mehal.  Activation-induced cell death of hepatic stellate cells by the innate immune system. , 2006, Gastroenterology.

[31]  R. Sun,et al.  Natural killer cells ameliorate liver fibrosis by killing activated stellate cells in NKG2D-dependent and tumor necrosis factor-related apoptosis-inducing ligand-dependent manners. , 2006, Gastroenterology.

[32]  F. Chisari,et al.  Immunobiology and pathogenesis of viral hepatitis. , 2006, Annual review of pathology.

[33]  S. Dooley,et al.  TGF-β/Smad Signaling in the Injured Liver , 2006 .

[34]  S. Dooley,et al.  TGF-beta/Smad signaling in the injured liver. , 2006, Zeitschrift fur Gastroenterologie.

[35]  G. Feldmann,et al.  Inducible nitric oxide synthase (iNOS) activity could be responsible for resistance or sensitivity to IFN-gamma-induced apoptosis in several human hepatoma cell lines. , 2006, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

[36]  D. Brenner,et al.  Erratum: Liver fibrosis (Journal of Clinical Investigation (2005) 115 (209-218) DOI:10.1172/JCI200524282) , 2005 .

[37]  R. Sun,et al.  Negative regulation of liver regeneration by innate immunity (natural killer cells/interferon-gamma). , 2004, Gastroenterology.

[38]  Won Ho Kim,et al.  IFN-gamma/STAT1 acts as a proinflammatory signal in T cell-mediated hepatitis via induction of multiple chemokines and adhesion molecules: a critical role of IRF-1. , 2004, American journal of physiology. Gastrointestinal and liver physiology.

[39]  Ivet Bahar,et al.  Inflammatory modulation of hepatocyte apoptosis by nitric oxide: in vivo, in vitro, and in silico studies. , 2004, Current molecular medicine.

[40]  C. Walker,et al.  Cell-mediated immunity and the outcome of hepatitis C virus infection. , 2004, Annual review of microbiology.

[41]  S. Thorgeirsson,et al.  Hepatocyte growth factor/c-met signaling pathway is required for efficient liver regeneration and repair. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[42]  H. Jaeschke,et al.  Functional importance of ICAM-1 in the mechanism of neutrophil-induced liver injury in bile duct-ligated mice. , 2004, American journal of physiology. Gastrointestinal and liver physiology.

[43]  R. Knight,et al.  STAT-1 Interacts with p53 to Enhance DNA Damage-induced Apoptosis* , 2004, Journal of Biological Chemistry.

[44]  R. Purcell,et al.  Genomic analysis of the host response to hepatitis B virus infection. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[45]  M. Neurath,et al.  A key pathogenic role for the STAT1/T‐bet signaling pathway in T‐cell–mediated liver inflammation , 2003, Hepatology.

[46]  Yoshifumi Watanabe,et al.  Interferon‐γ induces reactive oxygen species and endoplasmic reticulum stress at the hepatic apoptosis , 2003, Journal of cellular biochemistry.

[47]  N. Van Rooijen,et al.  ICAM-1 triggers liver regeneration through leukocyte recruitment and Kupffer cell-dependent release of TNF-alpha/IL-6 in mice. , 2003, Gastroenterology.

[48]  B. Wiedenmann,et al.  Downregulation of p21waf/cip-1 mediates apoptosis of human hepatocellular carcinoma cells in response to interferon-γ , 2003 .

[49]  R. Purcell,et al.  CD8+ T Cells Mediate Viral Clearance and Disease Pathogenesis during Acute Hepatitis B Virus Infection , 2003, Journal of Virology.

[50]  B. Wiedenmann,et al.  Downregulation of p21(waf/cip-1) mediates apoptosis of human hepatocellular carcinoma cells in response to interferon-gamma. , 2003, Experimental cell research.

[51]  Z. Tian,et al.  Opposing roles of STAT1 and STAT3 in T cell-mediated hepatitis: regulation by SOCS. , 2002, The Journal of clinical investigation.

[52]  J. Hoofnagle.  Course and outcome of hepatitis C , 2002, Hepatology.

[53]  D. Geller,et al.  Blockade of the L‐arginine/NO synthase pathway worsens hepatic apoptosis and liver transplant preservation injury , 2002, Hepatology.

[54]  M. Matsui,et al.  Downregulation of the proteasome subunits, transporter, and antigen presentation in hepatocellular carcinoma, and their restoration by interferon‐γ , 2002, Journal of gastroenterology and hepatology.

[55]  J. Kaldor,et al.  Is severe liver disease a common outcome for people with chronic hepatitisC? , 2002, Journal of gastroenterology and hepatology.

[56]  F. Chisari,et al.  Interferon-Regulated Pathways That Control Hepatitis B Virus Replication in Transgenic Mice , 2002, Journal of Virology.

[57]  R. Bartenschlager,et al.  Interferon‐γ inhibits replication of subgenomic and genomic hepatitis C virus RNAs , 2002 .

[58]  Kazuhiko Yamamoto,et al.  Interferon- γ Inhibits Hepatocyte Growth Factor-Stimulated Cell Proliferation of Human Bronchial Epithelial Cells , 2002 .

[59]  D. Adams,et al.  Recruitment of lymphocytes to the human liver , 2002, Immunology and cell biology.

[60]  Hansjörg Hauser,et al.  Review: Activities of IRF-1 , 2002 .

[61]  R. Bartenschlager,et al.  Interferon-gamma inhibits replication of subgenomic and genomic hepatitis C virus RNAs. , 2002, Hepatology.

[62]  Hansjörg Hauser,et al.  Activities of IRF-1. , 2002, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

[63]  G. Romeo,et al.  IRF-1 as a negative regulator of cell proliferation. , 2002, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

[64]  Jie Liu,et al.  O(2)-Vinyl 1-(pyrrolidin-1-yl)diazen-1-ium-1,2-diolate protection against D-galactosamine/endotoxin-induced hepatotoxicity in mice: genomic analysis using microarrays. , 2002, Journal of Pharmacology and Experimental Therapeutics.

[65]  Kazuhiko Yamamoto,et al.  Interferon-gamma inhibits hepatocyte growth factor-stimulated cell proliferation of human bronchial epithelial cells: upregulation of p27(kip1) cyclin-dependent kinase inhibitor. , 2002, American journal of respiratory cell and molecular biology.

[66]  F. Chisari,et al.  Blocking Chemokine Responsive to γ–2/Interferon (IFN)-γ Inducible Protein and Monokine Induced by IFN-γ Activity In Vivo Reduces the Pathogenetic but not the Antiviral Potential of Hepatitis B Virus–specific Cytotoxic T Lymphocytes , 2001, The Journal of experimental medicine.

[67]  F. Chisari,et al.  Determinants of Viral Clearance and Persistence during Acute Hepatitis C Virus Infection , 2001, The Journal of experimental medicine.

[68]  R. Flavell,et al.  Recognition of double-stranded RNA and activation of NF-κB by Toll-like receptor 3 , 2001, Nature.

[69]  R. Lanford,et al.  DNA Microarray Analysis of Chimpanzee Liver during Acute Resolving Hepatitis C Virus Infection , 2001, Journal of Virology.

[70]  T. Joh,et al.  Th1/Th2 cytokine profiles and their relationship to clinical features in patients with chronic hepatitis C virus infection , 2001, Journal of Gastroenterology.

[71]  M. Manns,et al.  Dissection of the Intracellular Pathways in Hepatocytes Suggests a Role for Jun Kinase and IFN Regulatory Factor-1 in Con A-Induced Liver Failure1 , 2001, The Journal of Immunology.

[72]  Chilakamarti V. Ramana,et al.  Biologic consequences of Stat1-independent IFN signaling , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[73]  B. J. Van den Eynde,et al.  Differential processing of class-I-restricted epitopes by the standard proteasome and the immunoproteasome. , 2001, Current opinion in immunology.

[74]  J. Wigginton,et al.  Primary Hepatocytes from Mice Treated with IL-2/IL-12 Produce T Cell Chemoattractant Activity that Is Dependent on Monokine Induced by IFN-γ (Mig) and Chemokine Responsive to γ-2 (Crg-2)1 , 2001, The Journal of Immunology.

[75]  A. Sette,et al.  Virus‐specific CD8+ T cells with type 1 or type 2 cytokine profile are related to different disease activity in chronic hepatitis C virus infection , 2001, European journal of immunology.

[76]  F. Chisari,et al.  Noncytolytic control of viral infections by the innate and adaptive immune response. , 2001, Annual review of immunology.

[77]  J. Wigginton,et al.  Primary hepatocytes from mice treated with IL-2/IL-12 produce T cell chemoattractant activity that is dependent on monokine induced by IFN-gamma (Mig) and chemokine responsive to gamma-2 (Crg-2). , 2001, Journal of immunology.

[78]  Y. M. Kim,et al.  A broad-spectrum caspase inhibitor blocks concanavalin A-induced hepatitis in mice. , 2000, Clinical immunology.

[79]  Xiao-Rong Zeng,et al.  Regulation of Bcl-xL: a little bit of this and a little bit of STAT , 2000, Current opinion in oncology.

[80]  P. Keskinen,et al.  Interferon-induced gene expression and signaling in human hepatoma cell lines. , 2000, Journal of hepatology.

[81]  Tsunehiro Kobayashi,et al.  The Impact of Interferon Gamma Receptor Expression on the Mechanism of Escape From Host Immune Surveillance in Hepatocellular Carcinoma , 2000, Hepatology.

[82]  O. Delattre,et al.  IFN-β induces serine phosphorylation of Stat-1 in Ewing's sarcoma cells and mediates apoptosis via induction of IRF-1 and activation of caspase-7 , 2000, Oncogene.

[83]  L. Kaer,et al.  Critical contribution of liver natural killer T cells to a murine model of hepatitis. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[84]  T. Billiar,et al.  Cyclic Nucleotides Suppress Tumor Necrosis Factor α-Mediated Apoptosis by Inhibiting Caspase Activation and Cytochrome cRelease in Primary Hepatocytes via a Mechanism Independent of Akt Activation* , 2000, The Journal of Biological Chemistry.

[85]  F. Chisari,et al.  Nitric Oxide Inhibits Hepatitis B Virus Replication in the Livers of Transgenic Mice , 2000, The Journal of experimental medicine.

[86]  F. Nicoletti,et al.  ESSENTIAL PATHOGENETIC ROLE FOR INTERFERON (IFN-)γ IN CONCANAVALIN A-INDUCED T CELL-DEPENDENT HEPATITIS: EXACERBATION BY EXOGENOUS IFN-γ AND PREVENTION BY IFN-γ RECEPTOR-IMMUNOGLOBULIN FUSION PROTEIN , 2000 .

[87]  J. Yee,et al.  The IFN Regulatory Factor Family Participates in Regulation of Fas Ligand Gene Expression in T Cells , 2000, The Journal of Immunology.

[88]  F. Chisari,et al.  Relative Sensitivity of Hepatitis B Virus and Other Hepatotropic Viruses to the Antiviral Effects of Cytokines , 2000, Journal of Virology.

[89]  Mikhail Chernov,et al.  Regulation of c‐myc expression by IFN‐γ through Stat1‐dependent and ‐independent pathways , 2000 .

[90]  G R Stark,et al.  Regulation of c-myc expression by IFN-gamma through Stat1-dependent and -independent pathways. , 2000, The EMBO journal.

[91]  F. Nicoletti,et al.  Essential pathogenetic role for interferon (IFN-)gamma in concanavalin A-induced T cell-dependent hepatitis: exacerbation by exogenous IFN-gamma and prevention by IFN-gamma receptor-immunoglobulin fusion protein. , 2000, Cytokine.

[92]  P. Boros,et al.  Cytokine profiles in early rejection following OKT3 treatment in liver transplant patients. , 2000, Mediators of inflammation.

[93]  K. Okita,et al.  Augmenter of liver regeneration (ALR) may promote liver regeneration by reducing natural killer (NK) cell activity in human liver diseases , 2000, Journal of Gastroenterology.

[94]  T. Mak,et al.  Protection against the mortality associated with disease models mediated by TNF and IFN-gamma in mice lacking IFN regulatory factor-1. , 1999, Journal of immunology.

[95]  D. Adams,et al.  Chemokine and chemokine receptor interactions provide a mechanism for selective T cell recruitment to specific liver compartments within hepatitis C-infected liver. , 1999, Journal of immunology.

[96]  A. Wendel,et al.  Concanavalin A hepatotoxicity in mice: Tumor necrosis factor–mediated organ failure independent of caspase‐3–like protease activation , 1999, Hepatology.

[97]  T. Naka,et al.  Negative regulation of cytokine signaling: STAT-induced STAT inhibitor. , 1999, Trends in biochemical sciences.

[98]  T. Akaike,et al.  IRF-1 is an essential mediator in IFN-gamma-induced cell cycle arrest and apoptosis of primary cultured hepatocytes. , 1999, Biochemical and biophysical research communications.

[99]  J. Massagué,et al.  Inhibition of transforming growth factor-β/SMAD signalling by the interferon-γ/STAT pathway , 1999, Nature.

[100]  J. G. Zhang,et al.  Negative regulation of cytokine signaling by the SOCS proteins. , 1999, Cold Spring Harbor symposia on quantitative biology.

[101]  C. Biron,et al.  Natural killer cells in antiviral defense: function and regulation by innate cytokines. , 1999, Annual review of immunology.

[102]  J. Massagué,et al.  Inhibition of transforming growth factor-beta/SMAD signalling by the interferon-gamma/STAT pathway. , 1999, Nature.

[103]  Y. Iwakura,et al.  Involvement of Fas/Fas ligand system‐mediated apoptosis in the development of concanavalin A‐induced hepatitis , 1998, European journal of immunology.

[104]  C. Lowenstein,et al.  Impaired liver regeneration in inducible nitric oxide synthasedeficient mice. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[105]  M. Burdick,et al.  PROLIFERATIVE EFFECTS OF CXC CHEMOKINES IN RAT HEPATOCYTES IN VITRO AND IN VIVO , 1998, Shock.

[106]  T. Nakamura,et al.  FK506 promotes liver regeneration by suppressing natural killer cell activity , 1998, Journal of gastroenterology and hepatology.

[107]  L. Moldawer,et al.  Disparate Roles for TNF-α and Fas Ligand in Concanavalin A-Induced Hepatitis , 1998, The Journal of Immunology.

[108]  P. Allavena,et al.  Differential Expression of Chemokine Receptors and Chemotactic Responsiveness of Type 1 T Helper Cells (Th1s) and Th2s , 1998, The Journal of experimental medicine.

[109]  L. Moldawer,et al.  Disparate roles for TNF-alpha and Fas ligand in concanavalin A-induced hepatitis. , 1998, Journal of immunology.

[110]  N. Young,et al.  Inhibition of interferon regulatory factor-1 expression results in predominance of cell growth stimulatory effects of interferon-gamma due to phosphorylation of Stat1 and Stat3. , 1997, Blood.

[111]  T. Billiar,et al.  Nitric Oxide Inhibits Apoptosis by Preventing Increases in Caspase-3-like Activity via Two Distinct Mechanisms* , 1997, The Journal of Biological Chemistry.

[112]  T. Billiar,et al.  Nitric oxide reversibly inhibits seven members of the caspase family via S-nitrosylation. , 1997, Biochemical and biophysical research communications.

[113]  M. Rolfe,et al.  Tumour necrosis factor alpha (TNF alpha) suppresses apoptosis and induces DNA synthesis in rodent hepatocytes: a mediator of the hepatocarcinogenicity of peroxisome proliferators? , 1997, Carcinogenesis.

[114]  Simon C Watkins,et al.  Differential effects of nonselective nitric oxide synthase (NOS) and selective inducible NOS inhibition on hepatic necrosis, apoptosis, ICAM-1 expression, and neutrophil accumulation during endotoxemia. , 1997, Nitric oxide : biology and chemistry.

[115]  J. Stamler,et al.  Nitric Oxide Inhibits Fas-induced Apoptosis* , 1997, The Journal of Biological Chemistry.

[116]  Y. Chrétien,et al.  Risk factors for cirrhosis in patients with chronic hepatitis C virus infection: Results of a case‐control study , 1997, Hepatology.

[117]  V. Pasquetto,et al.  Differential target cell sensitivity to CTL-activated death pathways in hepatitis B virus transgenic mice. , 1997, Journal of immunology.

[118]  M. Oren,et al.  Mdm2 promotes the rapid degradation of p53 , 1997, Nature.

[119]  T. Akaike,et al.  Analysis of IFN-gamma-induced cell cycle arrest and cell death in hepatocytes. , 1997, Journal of biochemistry.

[120]  G. Tiegs.  Experimental hepatitis and role of cytokines. , 1997, Acta gastro-enterologica Belgica.

[121]  M. Nehls,et al.  Suppression of Apoptosis by Nitric Oxide via Inhibition of Interleukin-1β–converting Enzyme (ICE)-like and Cysteine Protease Protein (CPP)-32–like Proteases , 1997, The Journal of experimental medicine.

[122]  C. Rice,et al.  The role of hepatitis C virus-specific cytotoxic T lymphocytes in chronic hepatitis C. , 1997, Journal of immunology.

[123]  T. Parmely,et al.  An Interferon-γ-activated Site (GAS) Is Necessary for Full Expression of the Mouse iNOS Gene in Response to Interferon-γ and Lipopolysaccharide* , 1997, The Journal of Biological Chemistry.

[124]  A. Alberti,et al.  Lack of correlation between hepatitis C virus genotypes and clinical course of hepatitis C virus‐related cirrhosis , 1997, Hepatology.

[125]  T. Parmely,et al.  An interferon-gamma-activated site (GAS) is necessary for full expression of the mouse iNOS gene in response to interferon-gamma and lipopolysaccharide. , 1997, The Journal of biological chemistry.

[126]  M. Burdick,et al.  HEPATIC INFLAMMATION FOLLOWING 70% HEPATECTOMY MAY BE RELATED TO UP‐REGULATION OF EPITHELIAL NEUTROPHIL ACTIVATING PROTEIN‐78 , 1996, Shock.

[127]  S. Küsters,et al.  Interferon gamma plays a critical role in T cell-dependent liver injury in mice initiated by concanavalin A. , 1996, Gastroenterology.

[128]  H. Fujiwara,et al.  Critical involvement of interferon γ in the pathogenesis of T‐cell activation‐associated hepatitis and regulatory mechanisms of interleukin‐6 for the manifestations of hepatitis , 1996, Hepatology.

[129]  Xin-Yuan Fu,et al.  Cell Growth Arrest and Induction of Cyclin-Dependent Kinase Inhibitor p21WAF1/CIP1 Mediated by STAT1 , 1996, Science.

[130]  A. Benedetti,et al.  Interferon gamma decreases hepatic stellate cell activation and extracellular matrix deposition in rat liver fibrosis , 1996, Hepatology.

[131]  F. Chisari,et al.  Intracellular inactivation of the hepatitis B virus by cytotoxic T lymphocytes. , 1996, Immunity.

[132]  T. Taniguchi,et al.  An IRF-1-dependent pathway of DNA damage-induced apoptosis in mitogen-activated T lymphocytes , 1995, Nature.

[133]  J. Darnell,et al.  Maximal activation of transcription by statl and stat3 requires both tyrosine and serine phosphorylation , 1995, Cell.

[134]  T. Starzl,et al.  Changes of liver-resident NK cells during liver regeneration in rats. , 1995, Journal of immunology.

[135]  T. Akaike,et al.  Protective effect of hepatocyte growth factor on interferon‐gamma—induced cytotoxicity in mouse hepatocytes , 1995, Hepatology.

[136]  K. Kinzler,et al.  p53-dependent and independent expression of p21 during cell growth, differentiation, and DNA damage. , 1995, Genes & development.

[137]  F. Chisari,et al.  Hepatitis B virus immunopathogenesis. , 1995, Annual review of immunology.

[138]  D. Rockey,et al.  Interferon gamma inhibits lipocyte activation and extracellular matrix mRNA expression during experimental liver injury: implications for treatment of hepatic fibrosis. , 1994, Journal of investigative medicine : the official publication of the American Federation for Clinical Research.

[139]  C. Nathan,et al.  Role of interferon regulatory factor 1 in induction of nitric oxide synthase , 1994, The Journal of experimental medicine.

[140]  M. Leist,et al.  Murine hepatocyte apoptosis induced in vitro and in vivo by TNF-alpha requires transcriptional arrest. , 1994, Journal of immunology.

[141]  B. Mach,et al.  Regulation of MHC class II expression by interferon-gamma mediated by the transactivator gene CIITA. , 1994, Science.

[142]  O. Silvennoinen,et al.  Signaling by the cytokine receptor superfamily: JAKs and STATs. , 1994, Trends in biochemical sciences.

[143]  T. Taniguchi,et al.  Requirement for transcription factor IRF-1 in NO synthase induction in macrophages. , 1994, Science.

[144]  J. Darnell,et al.  A single phosphotyrosine residue of Stat91 required for gene activation by interferon-gamma. , 1993, Science.

[145]  S. Nagata,et al.  Lethal effect of the anti-Fas antibody in mice , 1993, Nature.

[146]  M. Farrar,et al.  The molecular cell biology of interferon-gamma and its receptor. , 1993, Annual review of immunology.

[147]  Toshikazu Nakamura,et al.  Direct evidence that hepatocyte growth factor is a hepatotrophic factor for liver regeneration and has a potent antihepatitis effect in vivo , 1992, Hepatology.

[148]  G. Forni,et al.  Distribution of interferon‐γ receptor in human tissues , 1992 .

[149]  S. Friedman,et al.  Inhibition of rat hepatic lipocyte activation in culture by interferon‐γ , 1992, Hepatology.

[150]  A. Wendel,et al.  A T cell-dependent experimental liver injury in mice inducible by concanavalin A. , 1992, The Journal of clinical investigation.

[151]  G. Forni,et al.  Distribution of interferon-gamma receptor in human tissues. , 1992, European journal of immunology.

[152]  T. Ishikawa,et al.  Apoptosis in cultured rat hepatocytes: The effects of tumour necrosis factor α and interferon γ , 1991 .

[153]  T. Ishikawa,et al.  Apoptosis in cultured rat hepatocytes: the effects of tumour necrosis factor alpha and interferon gamma. , 1991, The Journal of pathology.

[154]  N. Tamaoki,et al.  In vivo effects of anti-asialo GM1. I. Reduction of NK activity and enhancement of transplanted tumor growth in nude mice. , 1981, Journal of immunology.

[155]  T E Starzl,et al.  Liver transplantation. , 1967, Bulletin de la Societe internationale de chirurgie.